Background: Research on acute cystitis in men is scarce and treatment guidelines differ between countries. Improved antibiotic stewardship is needed.
Aim: To analyse antibiotic prescriptions and outcomes of Norwegian men diagnosed with cystitis in primary care.
In past decades, hybrid organizations and institutional complexity have received growing attention, yet questions remain about how hybrids manage institutional complexity in the Nordic welfare states. This article investigates how Norwegian social enterprises (SEs), a subset of hybrid organizations, internally manage contradictory demands when externally engaging with multiple logics. The data consists of interviews of leaders and staff members from five SEs, and the findings show that most institutional referents hold a public-sector logic which may crowd out the hybrid nature of SEs.
View Article and Find Full Text PDFEur J Clin Pharmacol
September 1996
Two preparations of diltiazem, controlled release (CR) given twice a day (b.i.d.
View Article and Find Full Text PDFDiscriminant analysis was performed on 12 standard lead data from 159 normal subjects (N) and 304 patients with first myocardial infarction (MI): the latter group consisted of 543 patients with acute non-Q wave MI (NQMI-group A), 68 patients with acute Q wave MI (QMI-group B) and 183 patients (group C) with recent (29) or old (154) QMI. A discriminant function was computed to separate optimally the larger group of QMI patients (group C) from N. A total of 7 features accounted for a specificity of 92% and a sensitivity of 89%.
View Article and Find Full Text PDFPercutaneous transluminal coronary angioplasty (PTCA) occlusion in five individual coronary artery distributions produced significant ST elevation ("current of injury") in 48/50 PTCAs in 46 patients. Four patients had PTCA of two separate coronary arteries. Two patients had no significant ischemic ST changes in the 16 simultaneous lead ECG and no chest pain with PTCA.
View Article and Find Full Text PDFIn a placebo-controlled trial 62 patients with chronic congestive heart failure (CHF) (New York Heart Association class III) had hydralazine (149 +/- 11 mg daily) or placebo added to conventional therapy. During 12 months' follow-up 27 patients dropped out, 15 of 32 in the hydralazine group and 12 of 30 among the control subjects. The 1-year mortality rate was 28% in the hydralazine group compared to 27% in the control group.
View Article and Find Full Text PDFActa Med Scand
November 1979
Out of 383 myocardial infarction (MI) patients aged below 70 years, 252 (66%) were judged after the third day in hospital to have had uncomplicated infarctions. These patients were allocated at random to two groups, one of which was given treatment for 8 days and the other for 15 days. No significant differences in mortality, morbidity or incapacity for work could be detected during the three-month period of follow-up.
View Article and Find Full Text PDF162 patients discharged from hospital after mycardial infarction were randomly allocated to two groups, one received alprenolol 400 mg daily and the other served as the control. The period of follow-up was two years and all other treatment given was standardized. The two groups did not differ with respect to risk factors for myocardial infarction, the course of the acute infarct or treatment during follow-up.
View Article and Find Full Text PDF